Trial Profile
Assessment of New Molecular Imaging Strategies for Prostate Cancer: Predictive Value of Established and Novel Positron Emission Tomography (PET) Radiotracers in Castration-Resistant Prostate Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Dec 2021
Price :
$35
*
At a glance
- Drugs Piflufolastat F18 (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Acronyms MISTER
- 20 Dec 2021 Status changed from active, no longer recruiting to completed.
- 06 Jul 2021 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.
- 15 Feb 2020 Interim results (n=13) presented at the 2020 Genitourinary Cancers Symposium